DOI: https://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20222725
Published: 2022-10-27

Open label, single arm, interventional multi-centered study to evaluate the efficacy and biophysical response of topical Soteri Skin cream in following skin conditions: atopic dermatitis, eczema, psoriasis and rosacea

Guneet Bedi, Pratisha P. Dash, Rafal M. Pielak

Abstract


Background: Eczema, also known as dermatitis, is characterized by skin inflammation, which presents as pruritus, skin dryness and erythema. Soteri cream, which was used in the study, contains Helianthus annus oil, glycerin, sodium hyaluronate, niacinamide and various ceramides. Niacinamide upregulates epidermal ceramide synthesis; thereby, strengthening epidermal barrier.

Methods: The study was conducted on 30 patients in total, out of which, 5 patients were of scalp (3) and palmar psoriasis (2), 10 of eczema, 10 of atopic dermatitis and 5 of rosacea. The above patients were the ones coming to Aayna clinic for their respective skin concerns. After doing clinical examination and taking written consent, patients were given Soteri skin cream, to apply twice daily on the area of concern. Follow up was done fortnightly for a month. Patient’s assessment in follow up visits was done with clinical photographic, along with dermoscopic photographic assessment after a month and by filling proforma for effects and side effects using VAS and SCORAD score (for atopic dermatitis).

Results: Complete symptomatic and visual improvement was seen in 3 patients of eczema, 2 of rosacea, 1 of scalp psoriasis and 6 of atopic dermatitis.

Conclusions: Soteri skin cream with its unique formulation of ceramides and niacinamide resulted in significant improvement in psoriasis, hand and nummular eczema, atopic dermatitis and rosacea. It is a steroid free, valuable line of treatment for chronic eczema.

 


Keywords


Eczema, Atopic dermatitis, Psoriasis, Rosacea, Soteri cream

Full Text:

PDF

References


Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D. Rook’s textbook of dermatology. 9th ed. Chichester, West Sussex, UK: John Wiley and Sons Inc; 2016.

Matts P, Oblong J, Bissett DL. A review of the range of effects of niacinamide in human skin. Int Fed Soc Cosmet Chem Mag. 2002;5:285-9.

Moberg C, Alderling M, Meding B. Hand eczema and quality of life: a population‐based study. Br J Dermatol. 2009;161(2):397-403.

Darsow U, Lubbe J, Taieb A, Seidenari S, Wollenberg A, Calza AM, et al. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol. 2005;19(3):286-95.

Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005;352(22):2314-24.

Brown S, Reynolds NJ. Atopic and non‐atopic eczema. BMJ. 2006;332(7541):584-8.

Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007;120(1):150-5.

Farber EM, Bright RD, Nall LM. Psoriasis. Arch Dermatol. 1968;98(3):248-59.

Comaish S. Autoradiographic studies of hair growth in various dermatoses: investigation into a possible circadian rhythm in human hair growth. Br J Dermatol. 1969;81:283-8.

Silva CY, Brown KL, Kurban AK, Mahalingam M. Psoriatic alopecia-fact or fiction? A clinicohistopathologic reappraisal. Indian J Dermatol Venereol Leprol. 2012;78(5):611-9.

Abdel‐Hamid IA, Salah AA, Moustafa YM, El‐Labban AM. Pityriasis amiantacea: a clinical and etiopathologic study of 85 patients. Int J Dermatol. 2003;42(4):260-4.

Farley E, Masrour S, McKey J, Menter A. Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality‐of‐life assessment tool. J Am Acad Dermatol. 2009;60(6):1024-31.

Kumar B, Sarawat A, Kaur I. Palmoplantar lesions in psoriasis: a study of 3065 patients. Acta Derm Venereol. 2002;82(3):192-5.

Powell FC. Clinical practice: rosacea. N Engl J Med. 2005;352(8):793-803.

Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol. 2000;143(3):524-31.

Bains P, Kaur M, Kaur J, Sharma S. Nicotinamide: Mechanism of action and indications in dermatology. Indian J Dermatol Venereol Leprol. 2018;84(2):234-7.

Bissett DL. Common cosmeceuticals. Clin Dermatol. 2009;27(5):435-45.

Chandrashekar BS, Soumya S. Effectiveness and safety of topical under-eye serum in patients with periorbital hyperpigmentation: an open-label single arm prospective study. J Clin Aesthet Dermatol. 2022;15(2):18-22.

Savoia A, Accardo C, Vannini F, Pasquale B, Baldi A. Outcomes in thread lift for facial rejuvenation: a study performed with happy lift™ revitalizing. Dermatol Ther. 2014;4.

Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European task force on atopic dermatitis. Dermatology. 1993;186(1):23-31.